Material Agreements

Indivior Pharmaceuticals, Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $500,000,000 principal amount (effective 2026-03-17).

“On March 17, 2026, Indivior Pharmaceuticals, Inc. (the “ Company ”) issued $500,000,000 principal amount of its 0.625% Convertible Senior Notes due 2031”

AMERICAN REBEL HOLDINGS INC entered into a equity purchase valued at $525,000 (effective 2026-03-12).

“On March 12, 2026, the Company received a subscription agreement for the purchase of 70,000 shares of Series D Convertible Preferred Stock for $525,000.”

AMERICAN REBEL HOLDINGS INC entered into Securities Purchase Agreement with 1800 Diagonal Lending, LLC valued at $124,200 (effective 2026-03-09).

“On March 9, 2026, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending, LLC, an accredited investor (the “Lender”), pursuant to which the Lender made a loan to the Company, evidenced by a promissory note in the principal amount of $124,200 (the “Note”).”

Frontier Group Holdings, Inc. amended Amendment No. 20 to the A320 Family Aircraft Purchase Agreement with Airbus S.A.S. (effective 2026-03-11).

“On March 11, 2026, Frontier Airlines, Inc. (“Frontier”), a wholly owned subsidiary of Frontier Group Holdings, Inc. (the “Company”), entered into Amendment No. 20 (the “Amendment”) to the A320 Family Aircraft Purchase Agreement, dated September 30, 2011, with Airbus S.A.S. (“Airbus”).”

Confluent, Inc. entered into First Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $1,100,000,000 (effective 2026-03-17).

“On the Closing Date, Confluent and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “Trustee”), entered into the First Supplemental Indenture, dated as of the Closing Date (the “First Supplemental Indenture”), to the Indenture, dated as of December 13, 2021, by and between Confluent and the Trustee (the “Original Indenture” and, together with the First Supplemental Indenture, the “Indenture”), relating to Confluent’s 0% Convertible Senior Notes due 2027 (the “Notes”). As of the Closing Date, $1,100,000,000 aggregate principal amount of the Notes were outstanding.”

Bluejay Diagnostics, Inc. entered into Agreement with the purchasers named therein valued at $125,000 (effective 2024-03-14).

“On March 14, 2024, Bluejay Diagnostics, Inc. (the “Company”) entered into a securities purchase agreement (the “Agreement”)”

Synchrony Card Funding, LLC entered into Class A(2026-1) Underwriting Agreement with Barclays Capital Inc., J.P. Morgan Securities LLC and TD Securities (USA) LLC valued at Underwriting Agreement for Class A(2026-1) Notes (effective 2026-03-13).

“On March 13, 2026, Synchrony Card Funding, LLC (“ Funding ”) and Synchrony Bank entered into an Underwriting Agreement by and among Funding, Synchrony Bank, Barclays Capital Inc., J.P. Morgan Securities LLC and TD Securities (USA) LLC (the “ Class A(2026-1) Underwriting Agreement ”), with respect to certain notes (the “ Class A(2026-1) Notes ”) to be issued by Synchrony Card Issuance Trust (the “ Trust ”) pursuant to the Amended and Restated Master Indenture, dated as of May 1, 2018, as supplemented by the SynchronySeries Indenture Supplement, dated as of September 26, 2018, and the Class A(2026-1) Terms Document (as defined below), each between the Trust and The Bank of New York Mellon, as indenture trustee (the “ Indenture Trustee ”).”

New Fortress Energy Inc. entered into RSA with certain lenders and noteholders (effective 2026-03-17).

“On March 17, 2026, New Fortress Energy Inc. and certain of its subsidiaries (collectively, “ NFE ” or the “ Company ”) entered into a restructuring support agreement (together with all exhibits, annexes, schedules, and appendices thereto, the “ RSA ”) with certain of its lenders and noteholders”

Aterian, Inc. amended Amendment with Midcap Funding IV Trust, as administrative agent (effective 2026-03-13).

“On March 13, 2026, the Company entered into Amendment No. 5 (the “Amendment”) to the Credit and Security Agreement dated as of December 22, 2021 (the “Credit Agreement”) between the Company, together with certain of its subsidiaries party thereto as borrowers, the entities party thereto as lenders, and Midcap Funding IV Trust, as administrative agent.”

Reliance Global Group, Inc. amended Amendment No. 2 to Common Stock Purchase Agreement with White Lion Capital, LLC valued at Increased Commitment Amount to $50,000,000 and extended Commitment Period to December 31, 2028 (effective 2026-03-12).

“On March 12, 2026, the Company entered into Amendment No. 2 to the Common Stock Purchase Agreement (the “Amendment No. 2”) with White Lion Capital, LLC (the “Investor”).”

Reliance Global Group, Inc. entered into Full and Final Release and Settlement Agreement (Kreindler Settlement Agreement) with Eliezer Kreindler and Lazar's Group, Inc. valued at Cash settlement amount of $40,350 (effective 2026-03-11).

“On March 11, 2026, the Company entered into a Full and Final Release and Settlement Agreement (the “Kreindler Settlement Agreement,” and together with the Rubin Settlement Agreement, the “Settlement Agreements”) by and among the Company, RGH, Ezra S. Beyman, Debbie Beyman, Eliezer Kreindler and Lazar’s Group, Inc.”

Reliance Global Group, Inc. entered into Full and Final Release and Settlement Agreement (Rubin Settlement Agreement) with Eli Rubin and 93529113 Quebec Inc. d/b/a Excellent Photo valued at Cash settlement amount of $90,560 (effective 2026-03-13).

“On March 13, 2026, Reliance Global Group, Inc., a Florida corporation (the “Company”), entered into a Full and Final Release and Settlement Agreement (the “Rubin Settlement Agreement”) by and among the Company, Reliance Global Holdings, LLC (“RGH”), Ezra S. Beyman, Debbie Beyman, Eli Rubin and 93529113 Quebec Inc. d/b/a Excellent Photo.”

Clene Inc. entered into Year 3 Subaward with New York University (NYU) valued at up to $8.0 million (effective 2026-03-13).

“On March 13, 2026, the Company entered into a subaward agreement for the third year of the NIH Grant with New York University (“NYU”), the prime awardee, for up to $8.0 million during the period from September 1, 2025 to August 31, 2026 (the “Year 3 Subaward”).”

TaskUs, Inc. amended Second Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at term loans in an amount equal to $500,000,000 and received revolving commitments in an amount equal (effective 2026-03-11).

“entered into a Second Amended and Restated Credit Agreement (the “Second Amended and Restated Credit Agreement”) with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent.”

Longevity Health Holdings, Inc. entered into Common Stock Purchase Agreement with International Capital Partners LLC valued at approximately $200,000 (effective 2026-03-13).

“On March 13, 2026, Longevity Health Holdings, Inc., a Delaware corporation (the “Company”), entered into a Common Stock Purchase Agreement (the “Stock Purchase Agreement”) with International Capital Partners LLC, a Florida limited liability company (the “Purchaser”), pursuant to which the Company has agreed to sell, and the Purchaser has agreed to purchase, in a private placement (the “Offering”) 689,656 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a purchase price of $0.29 per Share for an aggregate purchase price of approximately $200,000.”

WinVest Acquisition Corp. amended Trust Agreement Extension Amendment with Continental Stock Transfer and Trust Company (effective 2026-03-16).

“nd Continental Stock Transfer and Trust Company (“Continental”), to extend the date on which Continental must liquidate the Trust Account (the “Liquidation Date”) from March 17, 2026 to April 17, 2026, and to allow the Company, without another”

WinVest Acquisition Corp. entered into Note with WinVest SPAC LLC valued at $180,000 (effective 2026-03-16).

“On March 16, 2026, the Company issued an unsecured promissory note in the principal amount of $180,000 (the “Note”) to the Sponsor”

Cyngn Inc. entered into Placement Agent Agreement with Aegis Capital Corp. valued at Placement agent fee of 7% of aggregate gross proceeds raised, plus reimbursement of certain expenses (effective 2026-03-16).

“In connection with the Offering, the Company entered into a Placement Agent Agreement (the “Placement Agent Agreement”) with Aegis Capital Corp. (the “Placement Agent”), as the exclusive placement agent in connection with the Offering. As compensation to the Placement Agent, the Company paid the Placement Agent a cash fee of 7% of the aggregate gross proceeds raised in the Offering and reimbursed certain expenses of the Placement Agent.”

Cyngn Inc. entered into Securities Purchase Agreement with Investors named on the signature page valued at Sale of 1,686,788 shares of common stock at $1.93 per share and 3,313,212 pre-funded warrants at $1. (effective 2026-03-16).

“On March 16, 2026, Cyngn Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the investors named on the signature page thereto, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”), 1,686,788 shares (the “Shares”) of its common stock, par value $0.00001 per share (“Common Stock”), at a purchase price of $1.93 per share and 3,313,212 pre-funded warrants (the “Pre-Funded Warrants”) to purchase shares of Common Stock, at a purchase price of $1.92999 per Pre-Funded Warrant.”

Israel Acquisitions Corp amended Third Amendment to Business Combination Agreement with Gadfin Ltd., Gadfin Regev Holdings Ltd. valued at Amendment to extend termination date to April 15, 2026 (effective 2026-03-13).

“On March 13, 2026, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel entered into a third amendment to the BCA (the “ Third BCA Amendment ”).”

Calumet, Inc. /DE entered into 9.75% Senior Notes due 2031 with initial purchasers valued at $150,000,000 aggregate principal amount, issued at 105% of par, plus accrued interest; net proceeds (effective 2026-03-17).

“On March 17, 2026, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), each a subsidiary of Calumet, Inc. (the “Company”), issued $150.0 million aggregate principal amount of the Issuers’ 9.75% Senior Notes due 2031 (the “Additional Notes”) in a private placement conducted pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Securities Act”).”

VisionWave Holdings, Inc. entered into Consulting and Share Purchase Agreement with Mr. Amos Cohen (controlling shareholder of Junko Solar Ltd.) valued at aggregate purchase price of $204,000 (effective 2026-03-11).

“On March 11, 2026, SolarDrone Ltd. (“SolarDrone”), an Israeli subsidiary of VisionWave Holdings, Inc. (Nasdaq: VWAV) (the “Company”), entered into a Consulting and Share Purchase Agreement (the “Agreement”) with Mr. Amos Cohen, the controlling shareholder of Junko Solar Ltd., an Israeli company engaged in solar panel maintenance and cleaning services.”

Drugs Made In America Acquisition II Corp. entered into Bridge Note with Alpha Multi Family Office valued at $150,000 (effective 2026-03-11).

“On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).”

INTEGRATED RAIL & RESOURCES INC. entered into Securities Purchase Agreement with B H, Inc. (effective 2026-03-09).

“On March 9, 2026, Integrated Rail & Resources Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with B H, Inc., a Utah corporation (the “Buyer”), pursuant to which the Company agreed to issue and deliver to the Buyer an aggregate of 7,056 shares of the Company’s Series A Convertible Preferred Stock, par value $0.0001 per share (the “Preferred Shares”).”

BBCMS Mortgage Trust 2025-C39 entered into Pooling and Servicing Agreement with Barclays Commercial Mortgage Securities LLC (effective 2025-12-01).

“On December 23, 2025, Barclays Commercial Mortgage Securities LLC (the “ Depositor ”) caused the issuance of the BBCMS Mortgage Trust 2025-C39, Commercial Mortgage Pass-Through Certificates, Series 2025-C39 (the “ Certificates ”), pursuant to a pooling and servicing agreement, dated and effective as of December 1, 2025 (the “ Pooling and Servicing Agreement ”), among the Depositor, as depositor, Midland Loan Services, a Division of PNC Bank, National Association, as master servicer, LNR Partners, LLC, as special servicer, Computershare Trust Company, National Association, as certificate administrator and as trustee, and Park Bridge Lender Services LLC, as operating advisor and as asset representations reviewer.”

DTE Electric Co entered into Clean Capacity Accelerator Agreement with Google LLC valued at Deploy up to 480 MW energy storage and 1,600 MW renewable generation to support electric service, 20 (effective 2026-03-16).

“On March 16, 2026, the Board of Directors of DTE Energy Company (“DTE Energy”) approved execution of a Primary Supply Agreement (“PSA”) and a Clean Capacity Accelerator Agreement (“CCAA”) between DTE Energy’s wholly-owned subsidiary DTE Electric Company (“DTE Electric”) and Google LLC (“Customer”) a wholly owned subsidiary of Alphabet Inc.”

DTE Electric Co entered into Primary Supply Agreement with Google LLC valued at Electric service at standard industrial rate for 1.0 GW data center, term through December 2047, min (effective 2026-03-16).

“On March 16, 2026, the Board of Directors of DTE Energy Company (“DTE Energy”) approved execution of a Primary Supply Agreement (“PSA”) and a Clean Capacity Accelerator Agreement (“CCAA”) between DTE Energy’s wholly-owned subsidiary DTE Electric Company (“DTE Electric”) and Google LLC (“Customer”) a wholly owned subsidiary of Alphabet Inc.”

JACOBS SOLUTIONS INC. entered into Revolving Credit Agreement with Bank of America, N.A., as administrative agent, Bank of America, N.A., BNP Paribas and Wells Fargo Bank, National Association, as co-syndication agents, The Toronto-Dominion Bank, New York Branch, HSBC Bank USA, National Association, U.S. Bank National Association and JPMorgan Chase Bank, N.A., as c valued at $1,500 million revolving facility maturing March 16, 2031 (effective 2026-03-16).

“On March 16, 2026, Jacobs Solutions Inc. (the “Company”), Jacobs Engineering Group Inc. ( “JEGI”) and certain of the Company’s wholly owned subsidiaries, as borrowers, entered into a credit agreement (the “Revolving Credit Agreement”) with the lenders party thereto, Bank of America, N.A., as administrative agent, Bank of America, N.A., BNP Paribas and Wells Fargo Bank, National Association, as co-syndication agents, The Toronto-Dominion Bank, New York Branch, HSBC Bank USA, National Association, U.S. Bank National Association and JPMorgan Chase Bank, N.A., as co-documentation agents, and BofA Securities, Inc., BNP Paribas Securities Corp. and Wells Fargo Securities, LLC, as joint lead arrangers and joint bookrunners.”

PAR TECHNOLOGY CORP entered into Indenture with U.S. Bank Trust Company, National Association valued at $265 million aggregate principal amount of 4.00% Convertible Senior Notes due 2031 (effective 2026-03-17).

“On March 17, 2026, PAR Technology Corporation (“PAR” or the “Company”) completed a private offering (the “Offering”) of $265 million aggregate principal amount of 4.00% Convertible Senior Notes due 2031 (the “Notes”), which amount includes $15 million aggregate principal amount of Notes issued pursuant to the initial purchasers’ exercise of their option to purchase additional Notes. The Notes were issued pursuant to an indenture, dated March 17, 2026 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee.”

BEAZER HOMES USA INC amended Amendment with JPMorgan Chase Bank, N.A. valued at $ 525 million (effective 2026-03-13).

“On March 13, 2026 , Beazer Homes USA, Inc. (the “Company”) executed a third amendment (the “Amendment”) to the Credit Agreement, dated as of October 13, 2022, among the Company, the several lenders from time to time parties thereto and JPMorgan Chase Bank, N.A., as an issuing lender and administrative agent (as amended on and prior to March 13, 2026 , the “Credit Agreement”).”

RADNOSTIX INC terminated Asset Purchase Agreement with American Fuel Resources, LLC (effective 2026-03-11).

“On March 16, 2026, Radnostix, Inc. (formerly International Isotopes, Inc., “RNX” or the “Company”), announced a mutual termination on March 11, 2026 of an Asset Purchase Agreement (the “APA”) dated February 8, 2024 that was entered into between RNX and its wholly-owned subsidiary International Isotopes Fluorine Products, Inc. (together with RNX, the “Seller”) and American Fuel Resources, LLC (“AFR”).”

TERAWULF INC. entered into Bridge Credit Agreement with Morgan Stanley Senior Funding, Inc. valued at $500 million (effective 2026-03-13).

“On March 13, 2026, TeraWulf Inc. (“TeraWulf” or the “Company”) entered into that certain Delayed-Draw Bridge Credit Agreement (with any and all amendments, restatements, supplements and/or other modifications thereto, the “Bridge Credit Agreement”), by and among Raylan Finance LLC, a Delaware limited liability company and a subsidiary of TeraWulf (“Holdings”), Raylan Data LLC, a Delaware limited liability company and a direct subsidiary of Holdings (the “Borrower”), Justified DataPower LLC, a Delaware limited liability company, a subsidiary of TeraWulf and an affiliate of the Borrower (the “Real Estate Guarantor”), Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent, and each lender party thereto from time to time.”

Waste Connections, Inc. entered into Eleventh Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $600,000,000 aggregate principal amount of 4.800% Senior Notes due 2036 (effective 2026-03-16).

“On March 16, 2026, Waste Connections, Inc. (“Waste Connections” or the “Company”) completed an underwritten public offering (the “Offering”) of $600,000,000 aggregate principal amount of its 4.800% Senior Notes due 2036 (the “Notes”).”

Duke Energy CORP amended Amendment No. 3 and Consent with Wells Fargo Bank, National Association, as Administrative Agent and Swingline Lender (effective 2026-03-16).

“On March 16, 2026, Duke Energy Corporation (the “Corporation”), Duke Energy Carolinas, LLC, Duke Energy Florida, LLC, Duke Energy Indiana, LLC, Duke Energy Kentucky, Inc., Duke Energy Ohio, Inc., Duke Energy Progress, LLC, and Piedmont Natural Gas Company, Inc., entered into an Amendment No. 3 and Consent (the “Amendment”) to amend the existing Amended and Restated Credit Agreement dated as of March 18, 2022, among the Corporation and each of such subsidiaries, as Borrowers, the lenders listed therein, and Wells Fargo Bank, National Association, as Administrative Agent and Swingline Lender.”

Kennedy-Wilson Holdings, Inc. amended Agreement and Plan of Merger with Kona Bidco, LLC and Kona Merger Subsidiary, Inc. valued at Amendment requiring two-thirds vote of Company Voting Stock as defined (effective 2026-03-15).

“On March 15, 2026, Kennedy Wilson entered into an Amendment to Agreement and Plan of Merger (the “Merger Agreement Amendment”, and the Original Merger Agreement, as amended, supplemented and otherwise modified by the Merger Agreement Amendment, the “Merger Agreement”) with Parent and Merger Sub.”

Phreesia, Inc. terminated Goldman Bridge Loan Facility with Goldman Sachs Bank USA valued at terminated without penalty and repaid all outstanding indebtedness and obligations (effective 2026-03-13).

“On March 13, 2026, in connection with the Company's entry into the Credit Facility, the Company terminated without penalty, and repaid all outstanding indebtedness and obligations under, (i) its existing bridge loan credit agreement (the "Goldman Bridge Loan Facility"), dated as of November 12, 2025, by and among the Company, as borrower, certain subsidiaries of the Company, as guarantors, the lenders from time to time party thereto, and Goldman Sachs Bank USA, as administrative agent and collateral agent for the lenders, sole lead arranger and bookrunner, and a lender”

Phreesia, Inc. entered into Credit Agreement with Capital One, National Association valued at senior secured revolving credit facility up to $275,000,000 (effective 2026-03-13).

“On March 13, 2026 (the "Closing Date"), Phreesia, Inc. (the "Company") and certain of its subsidiaries (collectively, the "Credit Parties") entered into a Credit Agreement (the "Credit Agreement") by and among the Company, as the borrower, the other Credit Parties, as guarantors, the financial institutions from time to time party thereto as lenders, and Capital One, National Association, a national banking association ("Capital One"), as agent for the lenders and for itself as lender, providing for a senior secured revolving credit facility (the "Credit Facility") up to an aggregate principal amount of $275,000,000”

ZEVRA THERAPEUTICS, INC. terminated Credit Agreement with HCR Stafford Fund II, L.P., HCR Potomac Fund II, L.P., Perceptive Credit Holdings IV, LP, and Alter Domus (US) LLC valued at $63.0 million (effective 2026-03-12).

“On March 12, 2026, the Company repaid in full all outstanding obligations under that certain Credit Agreement, dated as of April 5, 2024, by and among the Company, HCR Stafford Fund II, L.P., HCR Potomac Fund II, L.P., and Perceptive Credit Holdings IV, LP (collectively, the “Lenders”), and Alter Domus (US) LLC, as administrative agent (the “Credit Agreement”).”

ZEVRA THERAPEUTICS, INC. entered into Asset Purchase and Settlement Agreement with Commave Therapeutics SA valued at $50.0 million (effective 2026-03-13).

“On March 13, 2026, Zevra Therapeutics, Inc.(the “Company”) entered into an Asset Purchase and Settlement Agreement (the “Agreement”) with Commave Therapeutics SA (“Commave”) to sell certain assets of the Company to Commave and to resolve litigation pending in the Court of Chancery of the State of Delaware captioned Commave Therapeutics SA v. Zevra Therapeutics, Inc., C.A. No. 2024-0920-LWW (the “Litigation”) related to claims arising under the Collaboration and License Agreement between the parties dated September 3, 2019, as amended (the “AZSTARYS License Agreement”).”

Spirit Aviation Holdings, Inc. entered into Restructuring Support Agreement with Consenting DIP Lenders valued at Restructuring Support Agreement providing for DIP loan prepayments, cash use covenants, equity issua (effective 2026-03-13).

“On March 13, 2026, the Debtors entered into a Restructuring Support Agreement (the “ Restructuring Support Agreement ”) with certain holders (collectively, the “ Consenting DIP Lenders ”) of approximately (i) 74.6% of the aggregate principal amount of the new money term loans (the “ New Money DIP Loans ”) issued under that certain Superpriority Secured Priming Debtor-in-Possession Credit Agreement dated as of October 14, 2025 (as further amended, restated, amended and restated, supplemented, or otherwise modified from time to time), by and among Spirit Airlines, LLC, as Borrower, Spirit Aviation Holdings, Inc., as Holdings, the other Debtors party thereto as Guarantors, Wilmington Trust, National Association, as Administrative Agent and Collateral Agent, and the lenders from time to time party thereto (the “ DIP Credit Agreement ”); (ii) 71.8% of Roll-Up DIP Loans issued under the DIP Credit Agreement; and (iii) 60.0% of the Debtors’ non-rolled up PIK Toggle Senior Secured Notes due 20”

Fortune Brands Innovations, Inc. entered into Cooperation Agreement with Garden Investment Management, L.P. (effective 2026-03-16).

“On March 16, 2026, Fortune Brands Innovations, Inc. (the “ Company ”) entered into a Cooperation Agreement (the “ Cooperation Agreement ”) with Garden Investment Management, L.P. (“ GI ”).”

MSC INCOME FUND, INC. entered into Master Note Purchase Agreement with certain qualified institutional investors valued at $150,000,000 (effective 2026-03-12).

“On March 12, 2026, MSC Income Fund, Inc. (“MSC Income”) and certain qualified institutional investors entered into a Master Note Purchase Agreement (the “Note Purchase Agreement”), which governs the issuance of $150,000,000 in aggregate principal amount of 6.34% Series A Senior Notes due 2029 (the “Series A Notes”).”

Quipt Home Medical Corp. amended amendment to that certain amended and restated credit and guaranty agreement with First-Citizens Bank & Trust Company (effective 2026-03-13).

“On March 13, 2026, Parent entered into an amendment to that certain amended and restated credit and guaranty agreement, initially dated as of September 16, 2022”

Airbnb, Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at Governs $2.5 billion of Senior Notes: 4.400% Senior Notes due 2029, 4.650% Senior Notes due 2031, 5. (effective 2026-03-16).

“On March 16, 2026 (the “Closing Date”), the Company closed the Offering. The terms of the Notes are governed by an Indenture, dated as of the Closing Date (the “Base Indenture”), by and between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), as supplemented by the First Supplemental Indenture, dated as of the Closing Date (the “First Supplemental Indenture,” and, together with the Base Indenture, the “Indenture”), by and between the Company and the Trustee.”

Airbnb, Inc. entered into Underwriting Agreement with BofA Securities, Inc., Goldman Sachs & Co. LLC, and Morgan Stanley & Co. LLC valued at $2.5 billion aggregate principal amount of senior notes, consisting of $850.0 million 4.400% Senior (effective 2026-03-12).

“On March 12, 2026, Airbnb, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., Goldman Sachs & Co. LLC, and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein (collectively, the “Underwriters”), relating to the public offering (the “Offering”) by the Company of $2.5 billion aggregate principal amount of senior notes, consisting of $850.0 million aggregate principal amount of its 4.400% Senior Notes due 2029 (the “2029 Notes”), $850.0 million aggregate principal amount of its 4.650% Senior Notes due 2031 (the “2031 Notes”), and $800.0 million aggregate principal amount of its 5.250% Senior Notes due 2036 (together with the 2029 Notes and the 2031 Notes, the “Notes”).”

AH Realty Trust, Inc. entered into Agreement with unrelated third party (the "Buyer") valued at approximately $562.0 million (effective 2026-03-13).

“On March 13, 2026, certain wholly owned subsidiaries of AH Realty Trust, Inc. (the “Company”) entered into a purchase and sale agreement (the “Agreement”) with an unrelated third party (the “Buyer”) to sell 11 of the Company’s 14 multifamily properties for an aggregate purchase price of approximately $562.0 million in cash (the “Multifamily Disposition”).”

Acumen Pharmaceuticals, Inc. entered into Registration Rights Agreement with certain institutional accredited investors valued at registration for resale of the Shares pursuant to a registration statement to be filed with the SEC (effective 2026-03-13).

“In connection with the Private Placement, the Company and the Investors entered into a Registration Rights Agreement, dated March 13, 2026 (the “ Registration Rights Agreement ”), providing for the registration for resale of the Shares pursuant to a registration statement (the “ Registration Statement ”) to be filed with the Securities and Exchange Commission (the “ SEC ”) no later than two business days after the date on which the Company files with the SEC its Annual Report on Form 10-K for the fiscal year ended December 31, 2025.”

Acumen Pharmaceuticals, Inc. entered into Securities Purchase Agreement with certain institutional accredited investors valued at 10,833,331 shares of common stock at $3.30 per share; expected gross proceeds ~$35.75 million (effective 2026-03-13).

“On March 13, 2026, Acumen Pharmaceuticals, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain institutional accredited investors named therein (each, an “ Investor ” and collectively, the “ Investors ”), pursuant to which the Company agreed to sell to the Investors, in a private placement (the “ Private Placement ”), 10,833,331 shares (the “ Shares ”) of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), at an offering price of $3.30 per Share.”

Elicio Therapeutics, Inc. terminated Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC (effective 2026-03-16).

“On March 16, 2026, the Company delivered written notice to Jones to terminate the Jones Sales Agreement and the offering of shares contemplated thereby, effective upon delivery, pursuant to Section 12(b) of the Jones Sales Agreement.”

Elicio Therapeutics, Inc. entered into Sales Agreement with B. Riley Securities, Inc., JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. valued at $100.0 million (effective 2026-03-16).

“On March 16, 2026, Elicio Therapeutics, Inc. (the “ Company ”) entered into an At Market Issuance Sales Agreement (the “ Sales Agreement ”) with B. Riley Securities, Inc., JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. (the “ Agents ”) with respect to an at-the-market offering program under which the Company may issue and sell, from time to time at its sole discretion, shares of its common stock, par value $0.01 per share (the “ Common Stock ”), having an aggregate offering price of up to $100.0 million”